| Single-cell analyses of transcriptional heterogeneity during drug tolerance transition in cancer cells by RNA sequencing MCW Lee, FJ Lopez-Diaz, SY Khan, MA Tariq, Y Dayn, CJ Vaske, ... Proceedings of the National Academy of Sciences 111 (44), E4726-E4735, 2014 | 223 | 2014 |
| Novel third-generation EGFR tyrosine kinase inhibitors and strategies to overcome therapeutic resistance in lung cancer A Murtuza, A Bulbul, JP Shen, P Keshavarzian, BD Woodward, ... Cancer Research 79 (4), 689-698, 2019 | 188 | 2019 |
| A new role for the Krüppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function DA Slavin, NP Koritschoner, CC Prieto, FJ López-Díaz, B Chatton, ... Oncogene 23 (50), 8196-8205, 2004 | 122 | 2004 |
| Human pregnancy-specific glycoprotein 1a (PSG1a) induces alternative activation in human and mouse monocytes and suppresses the accessory cell-dependent T cell proliferation CC Motrán, FL Díaz, A Gruppi, D Slavin, B Chatton, JL Bocco Journal of leukocyte biology 72 (3), 512-521, 2002 | 80 | 2002 |
| Trypanosoma cruzi-induced immunosuppression: B cells undergo spontaneous apoptosis and lipopolysaccharide (LPS) arrests their proliferation during acute … E Zuniga, C Motran, CL Montes, FL Diaz, JL Bocco, A Gruppi Clinical & Experimental Immunology 119 (3), 507-515, 2000 | 80 | 2000 |
| In vivo expression of recombinant pregnancy‐specific glycoprotein 1a induces alternative activation of monocytes and enhances Th2‐type immune response CC Motrán, FL Diaz, CL Montes, JL Bocco, A Gruppi European Journal of Immunology 33 (11), 3007-3016, 2003 | 66 | 2003 |
| The Krüppel-like core promoter binding protein gene is primarily expressed in placenta during mouse development D Slavin, V Sapin, F Lopez-Diaz, P Jacquemin, N Koritschoner, ... Biology of reproduction 61 (6), 1586-1591, 1999 | 47 | 1999 |
| Coordinate transcriptional and translational repression of p53 by TGF-β1 impairs the stress response FJ López-Díaz, P Gascard, SK Balakrishnan, J Zhao, SV Del Rincon, ... Molecular cell 50 (4), 552-564, 2013 | 37 | 2013 |
| Dynamic regulation of CTCF stability and sub-nuclear localization in response to stress BJ Lehman, FJ Lopez-Diaz, TP Santisakultarm, L Fang, MN Shokhirev, ... PLoS genetics 17 (1), e1009277, 2021 | 26 | 2021 |
| Systemic Treatment Options for Brain Metastases from Non-Small-Cell Lung Cancer. A Bulbul, PM Forde, A Murtuza, B Woodward, H Yang, I Bastian, ... Oncology (08909091) 32 (4), 2018 | 18 | 2018 |
| Transcriptional control of the human pregnancy-specific glycoprotein 5 gene is dependent on two GT-boxes recognized by the ubiquitous specificity protein 1 (Sp1) transcription … R Nores, L Blanchon, F López-Dı́az, JL Bocco, LC Patrito, V Sapin, ... Placenta 25 (1), 9-19, 2004 | 17 | 2004 |
| Characterization of cellular states of CHO-K1 suspension cell culture through cell cycle and RNA-sequencing profiling I Tossolini, FJ López-Díaz, R Kratje, CC Prieto Journal of biotechnology 286, 56-67, 2018 | 13 | 2018 |
| RXRα regulates the pregnancy-specific glycoprotein 5 gene transcription through a functional retinoic acid responsive element F Lopez-Diaz, R Nores, G Panzetta-Dutari, D Slavin, C Prieto, ... Placenta 28 (8-9), 898-906, 2007 | 9 | 2007 |
| Actionable fusions detected by RNA-seq co-occur with PD-L1 expression and driver mutations in solid tumors patients M Shin, P Petersen, S Lau-Rivera, S Jung, S Agersborg, J Hechtman, ... Prostate 5, 4, 2022 | 1 | 2022 |
| TP53/NPM1-mutated acute myeloid leukemia as a molecularly distinct disease entity. FJ Scarpa, M Paul, R Daringer, WA Wolfson, F Lopez Diaz, S Agersborg, ... Journal of Clinical Oncology 39 (15_suppl), 7030-7030, 2021 | 1 | 2021 |
| P3. 12C. 01 BRAF Mutation Diversity and Impact on Clinical Outcomes in Non-Small Cell Lung Cancer K Lu, JP Shen, FJ Lopez-Diaz, A Leal, BD Woodward, V Velcheti, ... Journal of Thoracic Oncology 19 (10), S341, 2024 | | 2024 |
| 78P Real-world analysis of actionable gene fusions identified by NGS and correlation with IHC in 422 patients from the community H Husain, C Duong, S Lau-Rivera, N Montgomery, R Puentes, D Lyle, ... Annals of Oncology 35, S245, 2024 | | 2024 |
| A study of the gaps and opportunities with fusion detection beyond NTRKs on 422 patients from the community. H Husain, C Duong, S Rivera, N Montgomery, R Puentes, D Lyle, ... Journal of Clinical Oncology 42 (16_suppl), e15186-e15186, 2024 | | 2024 |
| Comparative analysis of actionable gene reporting in targeted panels versus comprehensive NGS testing for solid tumor samples. C Duong, R Puentes, N Montgomery, D Lyle, FJ Lopez-Diaz Journal of Clinical Oncology 42 (16_suppl), 11185-11185, 2024 | | 2024 |
| A study of the clinical utility of NTRKs only vs. comprehensive gene fusion panel testing from a single assay platform C Duong, S Lau-Rivera, R Jackson, P Kanagasunderam, R Hariri, ... Cancer Research 84 (6_Supplement), 1312-1312, 2024 | | 2024 |
